| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/12/2001 | WO2001025238A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 04/12/2001 | WO2001025237A1 Novel imidazopyridine carbonitrile compounds |
| 04/12/2001 | WO2001025228A1 Amine derivatives |
| 04/12/2001 | WO2001025217A1 New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 04/12/2001 | WO2001025213A2 Pyrrolo imidazole derivatives and their use as medicaments |
| 04/12/2001 | WO2001025212A2 Cyclic biphenyls, method for the production thereof, and their use as medicaments |
| 04/12/2001 | WO2001025210A2 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands |
| 04/12/2001 | WO2001025207A1 Novel nicotinonitrile compounds |
| 04/12/2001 | WO2001025204A1 Novel trisubstituted pyridine compounds |
| 04/12/2001 | WO2001025188A1 Novel carbamates and ureas |
| 04/12/2001 | WO2001025186A1 Novel ltb4 antagonist, method for the production thereof and its use as a medicament |
| 04/12/2001 | WO2001024823A1 Cd40 antagonist for treating psoriasis |
| 04/12/2001 | WO2001024815A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | WO2001024814A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 04/12/2001 | WO2001024811A1 April receptor (bcma) and uses thereof |
| 04/12/2001 | WO2001024803A2 Pharmaceutical compositions containing copper, salicylic acid and vitamines c |
| 04/12/2001 | WO2001024797A1 Integrin receptor antagonists |
| 04/12/2001 | WO2001024796A1 1,2,4-triazole derivatives, composition, process of making and methods of use |
| 04/12/2001 | WO2001024774A1 Ortho ester lipids |
| 04/12/2001 | WO2001024764A2 Cell targeting compositions and methods of using the same |
| 04/12/2001 | WO2001024763A2 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 04/12/2001 | WO2001024684A2 Methods for treatment of solid tumors and metastasis by gene therapy |
| 04/12/2001 | WO2001024637A1 Methods for treating solid tumors with irradiation and bacteria |
| 04/12/2001 | WO2001005382A8 Synergistic composition comprising daunorubicin derivatives and antimetabolite compounds |
| 04/12/2001 | WO2000071157A3 New vaccine formulations - 1 |
| 04/12/2001 | WO2000064938A3 Peptide homodimers or peptide heterodimers derived from interleukin 12 |
| 04/12/2001 | WO2000045805A3 Methods of inhibiting the hgf-met-upa-plasmin network with geldanamycin derivates |
| 04/12/2001 | WO2000004891A3 Anti-ulcer composition |
| 04/12/2001 | WO1999067283A3 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof |
| 04/12/2001 | WO1999057117A3 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 04/12/2001 | DE19948428A1 Neuer LTB¶4¶-Antagonist, Verfahren zu dessen Herstellung und dessen Verwendung als Arzneimittel New LTB¶4¶ antagonist, process for its preparation and its use as a medicament |
| 04/12/2001 | CA2406882A1 Diagnostic probes and therapeutics targeting upa and upar |
| 04/12/2001 | CA2388864A1 Ortho ester lipids |
| 04/12/2001 | CA2388487A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | CA2386806A1 Non-invasive tumor imaging by tumor-targeted bacteria |
| 04/12/2001 | CA2386795A1 Pyrrolo imidazole derivatives and their use as medicaments |
| 04/12/2001 | CA2386540A1 Novel carbamates and ureas |
| 04/12/2001 | CA2386533A1 Use of soluble costimulatory factor for tumor immuno-gene therapy |
| 04/12/2001 | CA2386517A1 Amine derivatives |
| 04/12/2001 | CA2386465A1 Compositions and methods for tumor-targeted delivery of effector molecules |
| 04/12/2001 | CA2386383A1 Growth factor polypeptides and nucleic acids encoding same |
| 04/12/2001 | CA2386377A1 Cell targeting compositions and methods of using the same |
| 04/12/2001 | CA2386374A1 Methods for treatment of solid tumors and metastasis by gene therapy |
| 04/12/2001 | CA2386248A1 Il13 mutants |
| 04/12/2001 | CA2386246A1 Altering gene expression with ssdna produced in vivo |
| 04/12/2001 | CA2386239A1 Methods for identifying rna binding compounds |
| 04/12/2001 | CA2386228A1 Stabilized liquid pharmaceutical compositions comprising tissue factor pathway inhibitor (tfpi) polypeptides |
| 04/12/2001 | CA2386199A1 Endozepine-like polypeptides and polynucleotides encoding same |
| 04/12/2001 | CA2386192A1 C-myc antisense-treated hematopoietic stem cell composition and method |
| 04/12/2001 | CA2386147A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
| 04/12/2001 | CA2386030A1 Integrin receptor antagonists |
| 04/12/2001 | CA2385703A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | CA2385528A1 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 04/12/2001 | CA2385251A1 Novel imidazopyridine carbonitrile compounds |
| 04/12/2001 | CA2385244A1 Novel nicotinonitrile compounds |
| 04/12/2001 | CA2385220A1 Antisense compositions and cancer-treatment methods |
| 04/12/2001 | CA2385210A1 Novel trisubstituted pyridine compounds |
| 04/12/2001 | CA2385127A1 Novel hepatoma-derived growth factor-like proteins, polynulceotides encoding them and methods of use |
| 04/12/2001 | CA2385045A1 Ifn-alpha homologues |
| 04/12/2001 | CA2384696A1 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen |
| 04/12/2001 | CA2382859A1 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 04/12/2001 | CA2382691A1 Oxazinoquinolones useful for the treatment of viral infections |
| 04/12/2001 | CA2379462A1 Human g-protein coupled receptor |
| 04/12/2001 | CA2348780A1 Regulatory/unfolding peptides of ezrin |
| 04/11/2001 | EP1090989A1 Human g-protein-coupled receptor |
| 04/11/2001 | EP1090927A1 Polypeptide (scFv) for the detection and removal of CA19-9 antigen positive cells |
| 04/11/2001 | EP1090926A1 Human G-protein coupled receptor |
| 04/11/2001 | EP1090914A2 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/11/2001 | EP1090908A2 Cyclobutane derivatives as inhibitors of protein farnesyltransferase |
| 04/11/2001 | EP1090637A2 Compositions and methods for treating or preventing inflammatory diseases |
| 04/11/2001 | EP1090146A1 Uses of dna-pk |
| 04/11/2001 | EP1090118A2 Human signal peptide-containing proteins |
| 04/11/2001 | EP1090114A2 Structured antisense nucleic acid molecules |
| 04/11/2001 | EP1090110A2 Human vault rna |
| 04/11/2001 | EP1090104A1 Methods of expanding and selecting disease associated t-cells |
| 04/11/2001 | EP1090038A2 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore |
| 04/11/2001 | EP1090014A1 Arylsulfonanilide phosphates |
| 04/11/2001 | EP1090012A1 Inhibitors of prenyl-protein transferase |
| 04/11/2001 | EP1090011A1 Inhibitors of prenyl-protein transferase |
| 04/11/2001 | EP1090010A1 Thienopyridine compounds, their production and use |
| 04/11/2001 | EP1090008A1 Syntheses of a variety of lamellarin compounds and analogues |
| 04/11/2001 | EP1090006A1 Alkyl ether analogs of chlorins having an n-substituted imide ring |
| 04/11/2001 | EP1089998A2 Epothilone derivatives and their synthesis and use |
| 04/11/2001 | EP1089989A1 Inhibitors of alpha4beta1 mediated cell adhesion |
| 04/11/2001 | EP1089964A1 Hydrazine derivatives |
| 04/11/2001 | EP1089766A2 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 04/11/2001 | EP1089764A2 A method for stimulating the immune system |
| 04/11/2001 | EP1089757A1 Hla binding peptides and their uses |
| 04/11/2001 | EP1089755A2 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
| 04/11/2001 | EP1089752A1 Alpha-keto oxadiazoles as serine protease inhibitors |
| 04/11/2001 | EP1089739A1 Cyclophosphamide coated tablets |
| 04/11/2001 | EP1089734A2 Use of tempo and tempo derivatives for inducing cell death |
| 04/11/2001 | EP1089727A1 Liposomal formulations of busulphan |
| 04/11/2001 | EP1089726A2 Composition comprising ss-hydroxy-ss-methylbutyric acid and at least one amino acid |
| 04/11/2001 | EP1089724A1 Therapeutic compositions and methods of use |
| 04/11/2001 | EP1089713A1 Temperature-sensitive liposomal formulation |
| 04/11/2001 | EP1068192A4 Novel crystalline complexes of baccatin iii with imidazole, 2-methylimidazole or isopropanol |
| 04/11/2001 | EP1056736A4 Alternate method for acylating 10-deacetylbaccatin iii selectively at the c-10 position |
| 04/11/2001 | EP1047682A4 Recovery of taxanes from plant material |
| 04/11/2001 | EP0984963B1 Novel compounds |